News and Events


Stay up-to-date with our latest news, developments and events

Latest News


 

News

DefiniGEN achieves Cyber Essentials certification
Read more >

News

DefiniGEN secures ISO 9001:2015 recertification
Read more >

News

The FDA Modernization Act 2.0 – Reducing animal use in drug development.
Read more >

News

DefiniGEN to showcase Phenotypic Screening Services at SLAS 2023
Read more >

News

Discover the screening approach which utilizes fully validated A1ATD iPSC-derived hepatocyte cells.
Read more >

News

DefiniGEN appoints Dr Chris Kirton as Chief Executive Officer

News

DefiniGEN Achieves ISO 9001: (2015) Certification
Read more >

News

DefiniGEN Secures £3.25 million in Funding to Fast-Track Growth
Read more >

News

DefiniGEN appoints Dr Ben Cons as Chairman of its Board
Read more >

News

DefiniGEN launches tool for coronavirus-specific intestinal cell research
Read more >

News

InSphero and DefiniGEN Receive Eurostars Grant to Develop Human Stem Cell-derived Screening Platform for Diabetes Drug Discovery
Read more >

Events

 

Events

SLAS2023 International Conference and Exhibition

Events

SOT 62nd Annual Meeting and ToxExpo 3rd February 2023

Events

ELRIG Drug Discovery 2022

Events

Cell & Gene Meeting on the Mesa

Events

DefiniGEN has been confirmed as a Silver sponsor for Discovery US: In Person.

Events

Harnessing the Potential of Next-Generation Disease Models with CRISPR - Webinar

Events

Oxford Global Drug Discovery 2021

Events

ELRIG - CRISPR in Drug Discovery 2020
definigen-logo-background-overlay
Advance your scientific discoveries with our disease model development and screening services.
Screening Services
Disease Modeling